Article Details
Retrieved on: 2021-12-10 01:02:20
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
NeuroSense Therapeutics Ltd., (NASDAQ: NRSN), a clinical-stage biotechnology company focused on discovering and developing treatments for patients ...
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here